Get the Stockscreener App
0.00
100.00%
-6.81
After Hours:
7.41
7.41
+
Portage Biotech Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.
See More
Previous Close:
$6.81
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$15.86M
Revenue:
-
Net Income/Loss:
$-67.28M
P/E Ratio:
0.00
EPS:
-94.66
Net Cash Flow:
$-9.80M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$15.82
Portage Biotech Inc Stock (PRTG) Company Profile
Compare PRTG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRTG
Portage Biotech Inc
|
0.00 | 15.86M | 0 | -67.28M | -9.80M | -94.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
437.15 | 110.25B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
693.50 | 73.04B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.16 | 59.98B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
907.98 | 54.90B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
193.22 | 40.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Portage Biotech Inc Stock (PRTG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
| Mar-07-22 | Initiated | H.C. Wainwright | Buy |
| Sep-21-21 | Initiated | Oppenheimer | Outperform |
| Sep-02-21 | Initiated | B. Riley Securities | Buy |
| Aug-19-21 | Initiated | Cantor Fitzgerald | Overweight |
Portage Biotech Inc Stock (PRTG) Latest News
Is Portage Biotech Inc. stock a dividend growth opportunityJuly 2025 Decliners & Fast Entry Momentum Alerts - newser.com
Published on: 2025-11-16 14:00:27 - newser.com
How Portage Biotech Inc. stock benefits from tech adoptionQuarterly Market Review & Stepwise Trade Execution Plans - newser.com
Published on: 2025-11-16 04:36:16 - newser.com
Published on: 2025-11-16 01:54:11 - newser.com
Is a relief rally coming for Portage Biotech Inc. holdersEarnings Miss & Community Supported Trade Ideas - newser.com
Using R and stats models for Portage Biotech Inc. forecastingPortfolio Performance Report & Advanced Swing Trade Entry Alerts - newser.com
How sentiment analysis helps forecast Portage Biotech Inc.Market Risk Analysis & Scalable Portfolio Growth Methods - newser.com
Analyzing Portage Biotech Inc. with multi timeframe chartsWeekly Profit Analysis & High Yield Stock Recommendations - newser.com
Is this a good reentry point in Portage Biotech Inc.Earnings Recap Summary & Short-Term High Return Strategies - newser.com
Is Portage Biotech Inc. stock entering bullish territoryWeekly Market Report & Fast Moving Stock Watchlists - newser.com
Published on: 2025-11-13 23:41:52 - newser.com
Published on: 2025-11-13 16:28:56 - newser.com
Published on: 2025-11-13 13:43:31 - newser.com
AlphaTON Capital and SingularityNET Join Forces to Accelerate Telegram’s Cocoon AI – Growing the Ethical, Decentralized AI Ecosystem - markets.businessinsider.com
Published on: 2025-11-13 02:23:56 - newser.com
Published on: 2025-11-12 17:45:39 - newser.com
Published on: 2025-11-12 14:07:14 - newser.com
Applying chart zones and confluence areas to Portage Biotech Inc.2025 Buyback Activity & Safe Capital Growth Stock Tips - newser.com
Regression analysis insights on Portage Biotech Inc. performanceWeekly Stock Recap & Weekly High Conviction Trade Ideas - newser.com
AlphaTON Capital Accelerates Global Growth with Strategic Appointment of William De’Ath as Chief Partnership Officer - markets.businessinsider.com
Published on: 2025-11-11 02:46:24 - newser.com
How to integrate Portage Biotech Inc. into portfolio analysis tools2025 Top Gainers & Safe Entry Momentum Tips - newser.com
Published on: 2025-11-10 07:35:32 - newser.com
Published on: 2025-11-10 05:05:20 - newser.com
Published on: 2025-11-10 04:52:32 - newser.com
Published on: 2025-11-09 03:59:35 - newser.com
Published on: 2025-11-09 03:35:28 - newser.com
Published on: 2025-11-08 06:01:29 - newser.com
Leading vs lagging indicators on Portage Biotech Inc. performanceWeekly Stock Recap & Verified Entry Point Signals - newser.com
Portage Biotech Inc Stock (PRTG) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.43%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):